---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-166018"
form_type: "8-K"
ticker: "MIRM"
cik: "0001759425"
company_name: "Mirum Pharmaceuticals, Inc."
filed_at: "2023-06-13T23:59:59+00:00"
generated_at: "2026-06-14T02:12:29.891164+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "high"
source: SEC EDGAR
---

# Mirum Pharmaceuticals announces results of 2023 annual meeting of stockholders

## Summary
- Elected Lon Cardon, William Fairey, and Timothy Walbert as Class I directors to serve until 2026.
- Each director received overwhelming support: Cardon 30.6M for, Fairey 30.4M for, Walbert 27.5M for.
- Ratified Ernst & Young as independent auditor for FY 2023 with 34.2M votes for, 3.4K against.
- Total shares outstanding and entitled to vote: 38,030,661 as of record date April 17, 2023.

## SEC filing metadata
- accession: 0001193125-23-166018
- form_type: 8-K
- ticker: MIRM
- cik: 0001759425
- company_name: Mirum Pharmaceuticals, Inc.
- filed_at: 2023-06-13T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1759425/000119312523166018/0001193125-23-166018-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1759425/000119312523166018/d522261d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-166018
- JSON: https://secwatch.observer/filing/0001193125-23-166018.json
- Plain text: https://secwatch.observer/filing/0001193125-23-166018.txt

## Key facts
- Shareholder Votes
  Mirum Pharmaceuticals, Inc. shareholders approved Election of Directors at the 2023-06-12 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-12
  source text: Proposal 1. Election of Directors The Company’s stockholders elected the three persons listed below as Class I directors, each to serve until the Company’s 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes Lon Cardon 30,587,478 410,063 3,228,927 William Fairey 30,362,034 635,507 3,228,927 Timothy Walbert 27,482,518 3,515,023 3,228,927
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759425/000119312523166018/0001193125-23-166018-index.htm
- Shareholder Votes
  Mirum Pharmaceuticals, Inc. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2023-06-12 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-12
  source text: Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The final voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 34,194,852 3,376 28,240
  evidence_url: https://www.sec.gov/Archives/edgar/data/1759425/000119312523166018/0001193125-23-166018-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.